- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
Dementia Seen in Younger Adults Shows Even More Brain Damage Than Alzheimer’s
White matter damage in the brains of adults with frontotemporal dementia is even greater than that seen in Alzheimer’s disease patients, a new study shows.
Frontotemporal dementia often affects people younger than 65, mainly causing personality and behavior changes and problems with language, rather than memory. The researchers assessed areas of brain damage called white matter hyperintensities, commonly associated with vascular health problems and Alzheimer’s disease.
“We were expecting to see similar amounts of white matter hyperintensities in frontotemporal dementia and Alzheimer’s disease, but we actually found higher levels in people with frontotemporal dementia,” said study author Ramón Landin-Romero, from the University of Sydney in Australia.
His team tracked 64 people with frontotemporal dementia, 65 people with Alzheimer’s disease and a control group of 66 healthy people without dementia. The participants had brain scans and other tests, and were followed for an average of two years.
Autopsy results were available for 13 of the people with frontotemporal dementia and five of the Alzheimer’s patients.
The total volume of white matter hyperintensities was larger in people with frontotemporal dementia than in Alzheimer’s disease patients or in the control group, according to the study published online Feb. 17 in the journal Neurology.
“We also expected to see that people with more severe disease would have more white matter hyperintensities, regardless of disease, but that was only true in people with frontotemporal dementia,” Landin-Romero said in a journal news release.
The average volume of white matter hyperintensities in people with frontotemporal dementia was 0.76 milliliters (mL) compared to 0.40 mL in Alzheimer’s patients and 0.12 mL in the control group.
In people with frontotemporal dementia, the amount of white matter hyperintensities was associated with the severity of both their symptoms and everyday difficulties, but was not associated with vascular risk factors such as high blood pressure and high cholesterol.
“In general, white matter hyperintensities have been associated with these vascular risk factors, so these results suggest that white matter hyperintensities are partly independent of vascular factors and associated with the progressive loss of brain integrity, more specifically the loss of brain cells, due to frontotemporal dementia,” Landin-Romero said.
“White matter hyperintensities should be viewed as a core feature of frontotemporal dementia and Alzheimer’s disease that can contribute to cognitive problems, not simply a marker of vascular disease,” he said.
More information
The Alzheimer’s Association has more on frontotemporal dementia.
SOURCE: Neurology, news release, Feb. 17, 2021
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.